申请人:Hoffmann-La Roche Inc.
公开号:US04549988A1
公开(公告)日:1985-10-29
There is presented 3H-2-benzazepines and 4,5-dihydro-3H-2-benzazepines of the formula ##STR1## wherein X is hydrogen, chloro or bromo, Y is hydrogen, fluoro or chloro with the proviso that X and Y cannot both be hydrogen and R.sub.1 is selected from the group consisting of hydrogen, bromo, chloro, iodo, a radical of the formula ##STR2## and a radical of the formula ##STR3## wherein R.sub.2 is hydrogen, phthalimido, lower alkyl, hydroxy, amino, monoalkylamino and dialkylamino and R.sub.3 is hydroxy, phthalimido or amino with the proviso that where R.sub.1 is other than hydrogen then the bonding at the 4,5-position is unsaturated, and the pharmaceutically acceptable salts thereof.
提供了式子为##STR1##的3H-2-苯并氮啶和4,5-二氢-3H-2-苯并氮啶,其中X为氢、氯或溴,Y为氢、氟或氯,但X和Y不能同时为氢,R.sub.1选自由氢、溴、氯、碘、式子##STR2##和式子##STR3##的基团,其中R.sub.2为氢、邻苯二甲酰亚胺、低级烷基、羟基、氨基、单烷基氨基和双烷基氨基,R.sub.3为羟基、邻苯二甲酰亚胺或氨基,但当R.sub.1不为氢时,4,5-位置的键合是不饱和的,以及其药学上可接受的盐。